NCT06592378 Opioid Management for Discharged Emergency Department Patients
| NCT ID | NCT06592378 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Addinex Technologies, Inc. |
| Condition | Bone Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-06-27 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-06-27 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to analyze the use of the Addinex system for opioid dispensing after ambulatory care to determine whether it will reduce opioid consumption, increase pill disposal, show variables that may predict opioid consumption, and determine whether this intervention is acceptable to patients.
Eligibility Criteria
Inclusion Criteria: * Ages six years and older * Ability to swallow pills * Isolated bone fracture * Planned to receive opioids in the post-treatment period * Not taking opioids daily prior to the procedure * English or Spanish-speaking * Able to give informed consent or a parent that can give informed consent * Ownership of and comfort using apps on a smartphone with compatible operating system * WIFI or cellular access * Patient not admitted to hospital Exclusion Criteria: * Recent opioid use (last 30 days or 2 or more prescriptions in the past 3 months * Impaired decisional capacity * In police custody * Ward of the state
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06592378 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, studying Bone Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06592378 currently recruiting?
Yes, NCT06592378 is actively recruiting participants. Contact the research team at Geoffrey_Capraro@brown.edu for enrollment information.
Where is the NCT06592378 trial being conducted?
This trial is being conducted at Providence, United States.
Who is sponsoring the NCT06592378 clinical trial?
NCT06592378 is sponsored by Addinex Technologies, Inc.. The trial plans to enroll 100 participants.